The above observations were supported by the work of Zhao and colleagues, who reported that Cur potentiates the anti-tumor activities against GBM by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways [14]. Here, NFKB1 is linked to glioblastoma.